CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg Rep 2022; 11(01): e30-e32
DOI: 10.1055/s-0042-1750427
Case Report: Vascular

Hybrid Arch Repair with Supra-Aortic Debranching and Using Castor Stent-Graft

Xijie Gao
1   Department of Interventional Radiology, The People's Hospital of Wanning County, Hainan, China
,
Guohong Liu
2   The People's Hospital of Wanning County, Hainan, China
,
Jun Lu
3   Department of Cardiovascular Surgery, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
,
Jianbo Zhao
4   Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
› Author Affiliations

Abstract

Background The management of aortic lesions involving the aortic arch in patients who cannot tolerate thoracotomy is a challenge.

Case Description A 32-year-old woman who underwent a giant aneurysm at the proximal end of the descending aorta with significant vascular wall calcification. The patient underwent Castor single-branched stent-grafting in the brachiocephalic trunk combined with surgical supra-aortic debranching, which avoided surgical aortic arch replacement and stent fenestration.reopening. The patient was followed up for 9 months, and surgery-related complications were not observed.

Conclusion Hybrid arch repair with supra-aortic debranching and using Castor single-branched stent can be used to treat aortic lesions involving the aortic arch.

Disclaimer

Castor single-branched stent-graft (Microport Medical, Shanghai, China) has been approved by the Chinese Food and Drug Administration and was the first domestic unibody branch stent-graft. Informed consent was obtained from the patient before the surgery.




Publication History

Received: 03 October 2021

Accepted: 22 March 2022

Article published online:
25 June 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Jing Z, Lu Q, Feng J. et al. Endovascular repair of aortic dissection involving the left subclavian artery by castor stent graft: a multicentre prospective trial. Eur J Vasc Endovasc Surg 2020; 60 (06) 854-861
  • 2 Fang C, Wang C, Liu K, Pang X. Early outcomes of left subclavian artery revascularization using castor single-branched stent-graft in the treatment of type B aortic dissection or intramural hematoma. Ann Thorac Cardiovasc Surg 2021; 27 (04) 251-259
  • 3 Uchida K, Minami T, Cho T. et al. Results of ascending aortic and arch replacement for type A aortic dissection. J Thorac Cardiovasc Surg. 2020; S0022–5223 (20) 30531-6
  • 4 Klocker J, Koell A, Erlmeier M, Goebel G, Jaschke W, Fraedrich G. Ischemia and functional status of the left arm and quality of life after left subclavian artery coverage during stent grafting of thoracic aortic diseases. J Vasc Surg 2014; 60 (01) 64-69
  • 5 Mangialardi N, Serrao E, Kasemi H, Alberti V, Fazzini S, Ronchey S. Chimney technique for aortic arch pathologies: an 11-year single-center experience. J Endovasc Ther 2014; 21 (02) 312-323
  • 6 Adeney KL, Siscovick DS, Ix JH. et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 2009; 20 (02) 381-387
  • 7 Huang H, Jiao Y, Zhang Y. et al. Implantation of unibody single-branched stent graft for patients with type B aortic dissections involving the left subclavian artery: 1-year follow-up outcomes. Cardiovasc Intervent Radiol 2017; 40 (11) 1678-1686